Lower respiratory tract illness and RSV prophylaxis in very premature infants.
about
Effectiveness of Palivizumab in Preventing RSV Hospitalization in High Risk Children: A Real-World PerspectiveConsensus conference on the appropriateness of palivizumab prophylaxis in respiratory syncytial virus disease.Respiratory syncytial virus disease in preterm infants in the U.S. born at 32-35 weeks gestation not receiving immunoprophylaxis.Prospective study of healthcare utilisation and respiratory morbidity due to RSV infection in prematurely born infants.Epidemiology and virology of acute respiratory infections during the first year of life: a birth cohort study in Vietnam.Preventing hospitalizations for respiratory syncytial virus infectionDiminished lung function, RSV infection, and respiratory morbidity in prematurely born infants.Palivizumab: a review of its use in the protection of high risk infants against respiratory syncytial virus (RSV)Randomised trial of high frequency oscillatory ventilation or conventional ventilation in babies of gestational age 28 weeks or less: respiratory and neurological outcomes at 2 years.Neonatal risk factors for respiratory morbidity during the first year of life among premature infants.Risk factors for hospitalization due to respiratory syncytial virus infection among infants in the Basque Country, Spain.Past, Present and Future Approaches to the Prevention and Treatment of Respiratory Syncytial Virus Infection in Children.Prévenir les hospitalisations pour l’infection par le virus respiratoire syncytial.
P2860
Q26830864-90185DC9-5EBD-44F4-80D4-0B969B77BBF6Q30245434-B24D2C4D-06D3-4748-AF33-9FDD31E87F80Q33630047-AAD00BE0-4D5A-4647-9A79-009954C8B8DDQ35537372-FB897726-864E-44ED-A629-D8262B1776D7Q35566693-273A2535-0F6F-4445-819F-C0EA77057D70Q36082195-8D6C4C39-7D71-4593-806D-0BC2881B4D67Q36153760-3D7833D0-C9B6-4E63-95A6-B9AD735197E8Q37290618-58DB94FA-A490-444F-9F3A-77D8EFC2B308Q41842555-957CB7CC-2A18-4CB9-94F2-6C6FF998DD8DQ43449647-7AAF87FE-30A2-4F37-A092-2D944C3A3243Q45417313-D4E336D1-5AA1-45E5-9547-EF6BAAF2D3D2Q50262223-5330FE8C-8109-4CA7-A8C3-57A7593BE7DBQ53932344-86E17BB7-C522-4995-9E07-0E1802928DAB
P2860
Lower respiratory tract illness and RSV prophylaxis in very premature infants.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Lower respiratory tract illness and RSV prophylaxis in very premature infants.
@ast
Lower respiratory tract illness and RSV prophylaxis in very premature infants.
@en
type
label
Lower respiratory tract illness and RSV prophylaxis in very premature infants.
@ast
Lower respiratory tract illness and RSV prophylaxis in very premature infants.
@en
prefLabel
Lower respiratory tract illness and RSV prophylaxis in very premature infants.
@ast
Lower respiratory tract illness and RSV prophylaxis in very premature infants.
@en
P2093
P2860
P356
P1476
Lower respiratory tract illness and RSV prophylaxis in very premature infants.
@en
P2093
Goldfarb G
Lacaze-Masmonteil T
Pinquier D
Truffert P
P2860
P304
P356
10.1136/ADC.2003.028282
P407
P577
2004-06-01T00:00:00Z